D206008 was found to increase the melanogenesis (melanin) concentration via the activation of the Akt/GSK-3ß/ß-catenin pathway, which links to an increase in MITF and TYR activity, as well as melanogenesis, suggesting a possible vitiligo therapy [304]. The gene discussed is AKT1; the disease is vitiligo.